Back
NYLI MacKay Muni Intermediate ETF Vs. United Therapeutics Corp. Industry Stock Comparison
Buy
62
MMIT
NYLI MacKay Muni Intermediate ETF
Last Price:
$24.37
Seasonality Move:
-1.92%
Buy
58
UTHR
United Therapeutics Corp.
Last Price:
$514.58
Seasonality Move:
5.61%
Buy
62
NYLI MacKay Muni Intermediate ETF (MMIT)
is a Buy
Is NYLI MacKay Muni Intermediate ETF a Buy, Sell or Hold?
-
The current NYLI MacKay Muni Intermediate ETF [MMIT] share price is $24.39. The Score for MMIT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
MMIT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
United Therapeutics Corp. (UTHR)
is a Buy
Is United Therapeutics Corp. a Buy, Sell or Hold?
-
The current United Therapeutics Corp. [UTHR] share price is $510.44. The Score for UTHR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MMIT Stock Price Chart
What is NYLI MacKay Muni Intermediate ETF's stock price today?
-
The NYLI MacKay Muni Intermediate ETF share price today is $24.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MMIT is experiencing slight selling pressure.
UTHR Stock Price Chart
What is United Therapeutics Corp.'s stock price today?
-
The United Therapeutics Corp. share price today is $510.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
MMIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 58.95 | Buy |
| Chaikin Money Flow: | -41043 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.3 - 24.38) | Buy |
| Bollinger Bands (100): | (24 - 24.42) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 126.4 | Buy |
| Relative Strength Index (14 RSI): | 66.74 | Buy |
| Chaikin Money Flow: | -289794 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (475.87 - 502.63) | Buy |
| Bollinger Bands (100): | (355.81 - 484.71) | Buy |
MMIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.35 | Buy |
| 20-day SMA: | 24.34 | Buy |
| 50-day SMA: | 24.36 | Buy |
| 200-day SMA: | 24 | Buy |
| 8-day EMA: | 24.35 | Buy |
| 20-day EMA: | 24.34 | Buy |
| 50-day EMA: | 23.91 | Buy |
| 200-day EMA: | 15.5 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 506.7 | Buy |
| 20-day SMA: | 492.57 | Buy |
| 50-day SMA: | 465.54 | Buy |
| 200-day SMA: | 360.13 | Buy |
| 8-day EMA: | 366.31 | Buy |
| 20-day EMA: | 201.57 | Buy |
| 50-day EMA: | 92.8 | Buy |
| 200-day EMA: | 24.96 | Buy |
NYLI MacKay Muni Intermediate ETF Earnings Growth & MMIT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
United Therapeutics Corp. Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $1.85 per share.
NYLI MacKay Muni Intermediate ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Corp. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||